Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon - Test2 - elhamkhani - TriplyDB

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

http://www.wikidata.org/entity/Q27488804

about

HCV Kinetic Models and Their Implications in Drug Development Quantification of viral infection dynamics in animal experiments Modelling hepatitis C therapy--predicting effects of treatment Spatiotemporal analysis of hepatitis C virus infection Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle.Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model Mathematical modeling of triphasic viral dynamics in patients with HBeAg-positive chronic hepatitis B showing response to 24-week clevudine therapy.Rapid emergence of protease inhibitor resistance in hepatitis C virus.Potential treatment options and future research to increase hepatitis C virus treatment response rate A perspective on modelling hepatitis C virus infection.Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration.Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.Quantification of Hepatitis C Virus Cell-to-Cell Spread Using a Stochastic Modeling Approach.Permissiveness of human hepatoma cell lines for HCV infection.A Computational Model of Inhibition of HIV-1 by Interferon-Alpha Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.Multiscale modeling of virus replication and spread.Type I interferon rapidly restricts infectious hepatitis C virus particle genesis.Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy.Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other Classes Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs.3D Spatially Resolved Models of the Intracellular Dynamics of the Hepatitis C Genome Replication Cycle.A siege of hepatitis: fighting a defiant virus.Quantitative Analysis of Hepatitis C NS5A Viral Protein Dynamics on the ER Surface.Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics.

P2860

Q26801602-0698B8FC-67BB-463B-8A7F-4E1505B8134F Q26824804-B4680C51-43CE-4CD7-ABB5-1B0B6D8059D7 Q26864673-059D6791-FC3F-49D5-8E34-4C648FE08E92 Q27320822-0ECC0BE5-A283-48A5-A9D2-80716AF7BDD9 Q28478310-3D04EC4F-8C8A-40C7-80AB-F3D9A26CF8B7 Q28541048-822BFE3F-DAFB-4417-A8E8-44328735D183 Q31129723-7BFFCB01-59E2-4033-B402-57DCA690B6D6 Q34035703-1D5E71E1-08DB-4684-990A-D2296F9DD84B Q34251341-720974A2-F711-4A8E-B5F3-4BF2CB7DC5FC Q34334375-444B4869-1527-452F-AF78-4D1F096C0ED1 Q34500227-6D0E121A-F16A-4B13-957A-EBD6B84C6317 Q34551913-9664B0EE-011A-475D-91FF-CC6D9653AF33 Q34576190-C9BF1631-9F88-49CB-B3C3-E56F535A2930 Q34759489-60C4FCE8-A28E-4C14-A427-918822FF0AF1 Q35012057-30E60C9C-975A-4994-91E0-F63B3B94E6E0 Q35610571-6334F066-CF8F-4696-B0A4-F93C56035236 Q35745457-617C09D1-2AAC-406E-A3BB-FF131D106870 Q35866290-F15402B4-2E79-48C6-8A11-5429E7D54BAD Q35969164-2B591328-B012-48D4-9F5F-DF9AD2F579EC Q36759689-F9C069A2-0EB7-40A9-AFF0-D98FFD471AF3 Q36810400-46A9767D-D805-4364-9D09-7BACB2FF104E Q37721750-20C14FFE-A3F9-4E03-AC68-97B8DD3F0697 Q38733905-AEA6BCEC-BEEE-4C00-AD16-F62B56FC5A34 Q38971183-08A63F0A-A919-40F3-912C-FD5AE3BA2165 Q40641829-2AD356F5-22D9-4A24-97B1-8633E3AAA56E Q40994676-730E6178-2615-42F6-A884-4112B2CE1C7F Q41727459-9B646529-C5DC-4772-B002-FF7C98E435F6 Q41925291-D46544A1-A1D1-43E0-904B-DAC6316F753E Q45368430-4D457B3A-0A17-41A5-91DE-E5D2CE85DAAE Q47216796-354E8396-FA8C-4FE1-B32D-E1DDE996374B Q54254238-D840CDFE-5032-4D7C-BD63-130EE3579E57

P2860

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

http://www.wikidata.org/entity/Q27488804

description

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2009-07)

@fr

articolo scientifico (pubblicato il 2009-07)

@it

artigo científico (publicado na 2009-07)

@pt

artículu científicu espublizáu en 2009

@ast

im Juli 2009 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: July 2009)

@en

vedecký článok (publikovaný 2009-07)

@sk

vetenskaplig artikel (publicerad på 2009-07)

@sv

name

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@ast

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@en

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@nl

type

label

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@ast

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@en

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@nl

prefLabel

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@ast

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@en

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@nl

P1433

Q27488804-4D96D880-6D25-45B6-B7C0-AEBC7568526D

P1476

Q27488804-FCF4E6C9-5618-4B24-9943-5E88285A4452

P2093

Q27488804-2378B24D-5926-4539-BEB3-7E67F0FC3342

Q27488804-DF257345-73B4-46DE-BF61-377E127F33AE

Q27488804-F2EB944B-A421-4498-8DB2-F792ACA6D2EF

P2860

Q27488804-05B0D5C6-54F8-4BA0-822F-283959A99BA9

Q27488804-07545B55-DD16-4235-91CA-8875100D0F88

Q27488804-09C53C2C-729C-417E-91A0-E286C5DE24F8

Q27488804-11B84D87-3EA2-4AB5-998D-3E9783051A12

Q27488804-23FE3813-08CF-428B-A21F-9043955EEE6D

Q27488804-476B6FC7-4E92-4AC1-A297-56B46F69F940

Q27488804-52C59ED2-9ABC-4B89-8A87-E5513A52888C

Q27488804-5C302E9A-7B13-4F21-A8E2-AC9259C016EF

Q27488804-68C9A9C6-09B2-462E-90EF-955EF46A4586

Q27488804-71457694-4597-42E6-ADA8-74EEA5676EC7

P304

Q27488804-99E271DC-6A65-4FD3-ADC7-A61419DDC719

P31

Q27488804-E57327A9-5163-491E-B8E1-BFB53333EE41

P3181

Q27488804-5F087F06-5E85-4203-B660-CF0A5A0E6448

P356

Q27488804-FE2C1FCD-BFB5-44BE-85F0-B8F5CD349C9E

P433

Q27488804-10A93EA4-86D7-41F2-9EC6-B25E380751B0

P478

Q27488804-FEF1FD14-D980-44BA-96FC-3DCBEF8D5E86

P50

Q27488804-891A29F8-CDBD-4268-84D3-9B99263C2513

P577

Q27488804-557146DE-DB01-4BFD-ACDA-03C01F545990

P698

Q27488804-24FFBC1A-27ED-41B3-9D05-28B285461F52

P932

Q27488804-9D500D5E-111F-47AC-82BE-A01DBD434A17

P3181

P356

P1433

Journal of Virology

P1476

Modeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha Interferon

@en

P2093

Bruno Sainz

http://www.w3.org/2001/XMLSchema#string

Harel Dahari

http://www.w3.org/2001/XMLSchema#string

Susan L Uprichard

http://www.w3.org/2001/XMLSchema#string

P2860

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Robust hepatitis C virus infection in vitro.

Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line

Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

Interference of hepatitis C virus RNA replication by short interfering RNAs

Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells

Interferon modulation of cellular microRNAs as an antiviral mechanism

Efficient initiation of HCV RNA replication in cell culture

P304

6383-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5068882

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.02612-08

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Alan S. Perelson

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19369346

http://www.w3.org/2001/XMLSchema#string

P932

2698578

http://www.w3.org/2001/XMLSchema#string